Daniel Perlmutter

Dan is Vice President of Business Development at LifeSci and leads the agency’s new business initiatives. Joining most recently from an eight and a half year career managing Bloomberg’s biotech and pharmaceutical client relationships, Dan has worked with notable clients such as Celgene, Pfizer, Novartis, Takeda, Allergan, and Teva.

He gained his knowledge in the sector by working directly with the companies’ business development, competitive intelligence, investor relations, and treasury departments. Prior to his time at Bloomberg, Dan worked for HedgeCo Networks, where he was Director of Advertising Sales, working with service providers to the hedge fund industry.

Dan graduated from the University of Massachusetts at Amherst, with a bachelor’s in English.